相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Arcuate Nucleus-Dependent Regulation of Metabolism-Pathways to Obesity and Diabetes Mellitus
Alexander Jais et al.
ENDOCRINE REVIEWS (2022)
Therapeutic potential of dopamine agonists in the treatment of type 2 diabetes mellitus
Md Tanvir Kabir et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2022)
Kisspeptin Overcomes GnRH Neuronal Suppression Secondary to Hyperprolactinemia in Humans
Katerina Hoskova et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Sexual function and depressive symptoms in men with hypoprolactinaemia secondary to overtreatment of prolactin excess: A pilot study
Robert Krysiak et al.
Endocrinologia Diabetes y Nutricion (2022)
Cardiometabolic profile of young women with hypoprolactinemia
Robert Krysiak et al.
ENDOCRINE (2022)
Association Between Prolactinoma and Body Mass Index
Farah Al Sabie et al.
ENDOCRINE PRACTICE (2021)
Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment
Rosa Pirchio et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Prolactin-Induced Adaptation in Glucose Homeostasis in Mouse Pregnancy Is Mediated by the Pancreas and Not in the Forebrain
Zin Khant Aung et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Adverse body composition and lipid parameters in patients with prolactinoma: a case-control study
Anna Sophia Posawetz et al.
BMC ENDOCRINE DISORDERS (2021)
Circulating prolactin level is increased in metabolically healthy obesity
Jia Liu et al.
ENDOCRINE CONNECTIONS (2021)
Change in Insulin Sensitivity and Lipid Profile After Dopamine Agonist Therapy in Patients With Prolactinoma
Ghayyur Khalil et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2021)
Impact of primary medical or surgical therapy on prolactinoma patients' BMI and metabolic profile over the long-term
Lukas Andereggen et al.
JOURNAL OF CLINICAL AND TRANSLATIONAL ENDOCRINOLOGY (2021)
Tumor volume improves preoperative differentiation of prolactinomas and nonfunctioning pituitary adenomas
Kyla Wright et al.
ENDOCRINE (2021)
Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor
Sarah N. Framnes-DeBoer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2020)
Pituitary-Tumor Endocrinopathies
Shlomo Melmed
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Time for a New Perspective on Prolactin in Metabolism
Yazmin Macotela et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2020)
The Association Between Prolactin and Metabolic Parameters in PCOS Women: A Retrospective Analysis
Haiyan Yang et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Metabolic regulation of kisspeptin - the link between energy balance and reproduction
Victor M. Navarro
NATURE REVIEWS ENDOCRINOLOGY (2020)
Metabolic functions of prolactin: Physiological and pathological aspects
Felicitas Lopez-Vicchi et al.
JOURNAL OF NEUROENDOCRINOLOGY (2020)
Low prolactin levels are associated with visceral adipocyte hypertrophy and insulin resistance in humans
Antonio J. Ponce et al.
ENDOCRINE (2020)
Prolactin - a pleiotropic factor in health and disease
Valerie Bernard et al.
NATURE REVIEWS ENDOCRINOLOGY (2019)
Prolactin and human weight disturbances: A puzzling and neglected association
Luis G. Sobrinho et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2019)
Hyperprolactinaemia
Irene Samperi et al.
JOURNAL OF CLINICAL MEDICINE (2019)
An investigation of the association between the level of prolactin in serum and type II diabetes
Najmeh Manshaei et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Role of prolactin/adenoma maximum diameter and prolactin/adenoma volume in the differential diagnosis of prolactinomas and other types of pituitary adenomas
Yinxing Huang et al.
ONCOLOGY LETTERS (2018)
Ablation of prolactin receptor increases hepatic triglyceride accumulation
Shanshan Shao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Prolactin improves hepatic steatosis via CD36 pathway
Pengzi Zhang et al.
JOURNAL OF HEPATOLOGY (2018)
The emerging Role(s) for Kisspeptin in Metabolism in Mammals
Andrew Wolfe et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Circulating prolactin concentrations and risk of type 2 diabetes in US women
Jun Li et al.
DIABETOLOGIA (2018)
Stress-Induced Hyperprolactinemia: Pathophysiology and Clinical Approach
Samara Levine et al.
OBSTETRICS AND GYNECOLOGY INTERNATIONAL (2018)
Prolactin Promotes Adipose Tissue Fitness and Insulin Sensitivity in Obese Males
Xarubet Ruiz-Herrera et al.
ENDOCRINOLOGY (2017)
Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis
Joan C. Lo et al.
HEMODIALYSIS INTERNATIONAL (2017)
Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas
Verena Schwetz et al.
METABOLIC BRAIN DISEASE (2017)
The role of postictal laboratory blood analyses in the diagnosis and prognosis of seizures
Robert D. Nass et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2017)
Running from Disease: Molecular Mechanisms Associating Dopamine and Leptin Signaling in the Brain with Physical inactivity, Obesity, and Type 2 Diabetes
Gregory N. Ruegsegger et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
Correlation of Serum Prolactin Level to Child Pugh Scoring System in Cirrhosis of Liver
Chaitanya H. Balakrishnan et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2017)
Hypothalamic-Pituitary-Ovarian Axis Reactivation by Kisspeptin-10 in Hyperprolactinemic Women With Chronic Amenorrhea
Robert P. Millar et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2017)
Kisspeptin-10 inhibits proliferation and regulates lipolysis and lipogenesis processes in 3T3-L1 cells and isolated rat adipocytes
Ewa Pruszynska-Oszmaek et al.
ENDOCRINE (2017)
Circulating Prolactin and Risk of Type 2 Diabetes: A Prospective Study
Tiange Wang et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism
Lokesh Kumar Sharma et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2016)
Minireview: CNS Mechanisms of Leptin Action
Jonathan N. Flak et al.
MOLECULAR ENDOCRINOLOGY (2016)
Spanish consensus on the risks and detection of antipsychotic drug-related hyperprolactinaemia
Angel L. Montejo et al.
REVISTA DE PSIQUIATRIA Y SALUD MENTAL (2016)
Is prolactin the missing link in adipose tissue dysfunction of polycystic ovary syndrome patients?
Alice Albu et al.
ENDOCRINE (2016)
Risk factors for accelerated atherosclerosis in young women with hyperprolactinemia
Milica Medic-Stojanoska et al.
MEDICAL HYPOTHESES (2015)
Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas
Renata S. Auriemma et al.
NEUROENDOCRINOLOGY (2015)
Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
Nazir A. Pala et al.
DIABETOLOGY & METABOLIC SYNDROME (2015)
Neuroendocrine Regulation of Lactation and Milk Production
William R. Crowley
COMPREHENSIVE PHYSIOLOGY (2015)
Age-dependent association of serum prolactin with glycaemia and insulin sensitivity in humans
R. Wagner et al.
ACTA DIABETOLOGICA (2014)
Challenges and pitfalls in the diagnosis of hyperprolactinemia
Lucio Vilar et al.
ARQUIVOS BRASILEIROS DE ENDOCRINOLOGIA E METABOLOGIA (2014)
Glucagon Regulates Hepatic Kisspeptin to Impair Insulin Secretion
Woo-Jin Song et al.
CELL METABOLISM (2014)
The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review
J. Peuskens et al.
CNS DRUGS (2014)
TIDAL WAVES: Network mechanisms in the neuroendocrine control of prolactin release
David J. Lyons et al.
FRONTIERS IN NEUROENDOCRINOLOGY (2014)
Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome
Dorte Glintborg et al.
HUMAN REPRODUCTION (2014)
Prevalence of obstructive sleep apnea in patients with prolactinoma before and after treatment with dopamine agonists
Flavia Regina Pinho Barbosa et al.
PITUITARY (2014)
Differential Stimulation of Insulin Secretion by GLP-1 and Kisspeptin-10
Tara A. Schwetz et al.
PLOS ONE (2014)
Prolactin prevents hepatocellular carcinoma by restricting innate immune activation of c-Myc in mice
Hadley J. Hartwell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Psychotropic-Induced Hyperprolactinemia: A Clinical Review
Adnan Ajmal et al.
PSYCHOSOMATICS (2014)
Higher doses of cabergoline further improve metabolic parameters in patients with prolactinoma regardless of the degree of reduction in prolactin levels
Alessandro Ciresi et al.
CLINICAL ENDOCRINOLOGY (2013)
PRLR Regulates Hepatic Insulin Sensitivity in Mice via STAT5
Junjie Yu et al.
DIABETES (2013)
Circulating Prolactin Associates With Diabetes and Impaired Glucose Regulation A population-based study
Tiange Wang et al.
DIABETES CARE (2013)
Effect of Cabergoline on Metabolism in Prolactinomas
Renata S. Auriemma et al.
NEUROENDOCRINOLOGY (2013)
Serum prolactin concentrations as risk factor of metabolic syndrome or type 2 diabetes?
Lisa Balbach et al.
BMC ENDOCRINE DISORDERS (2013)
Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma
Serap Soytac Inancli et al.
ENDOCRINE (2013)
Central Prolactin Modulates Insulin Sensitivity and Insulin Secretion in Diabetic Rats
Sunmin Park et al.
NEUROENDOCRINOLOGY (2012)
Influence of Prolactin and Calcium Gluconate Concentration on Permeation and Intestinal Absorption of Ca(II) Ions
Florian Ryszka et al.
PROTEIN AND PEPTIDE LETTERS (2012)
Bromocriptine for Diabetes Mellitus Type II
Guy Valiquette
CARDIOLOGY IN REVIEW (2011)
Bromocriptine: A Sympatholytic, D2-Dopamine Agonist for the Treatment of Type 2 Diabetes
Ralph A. DeFronzo
DIABETES CARE (2011)
Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats
Sunmin Park et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Identification of Prolactin-Sensitive GABA and Kisspeptin Neurons in Regions of the Rat Hypothalamus Involved in the Control of Fertility
Ilona C. Kokay et al.
ENDOCRINOLOGY (2011)
Prolactin and Lactation as Modifiers of Diabetes Risk in Gestational Diabetes
M. A. Ramos-Roman
HORMONE AND METABOLIC RESEARCH (2011)
Evidences for the Existence of a Low Dopaminergic Tone in Polycystic Ovarian Syndrome: Implications for OHSS Development and Treatment
Raul Gomez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
BMI and Metabolic Profile in Patients With Prolactinoma Before and After Treatment With Dopamine Agonists
Cintia M. dos Santos Silva et al.
OBESITY (2011)
Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy
Katarina Berinder et al.
PITUITARY (2011)
Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)
Alberto Fernandez et al.
CLINICAL ENDOCRINOLOGY (2010)
Prolactin Receptor Is Required for Normal Glucose Homeostasis and Modulation of β-Cell Mass during Pregnancy
Carol Huang et al.
ENDOCRINOLOGY (2009)
The effects of hyperprolactinemia on bone and fat
Amal Shibli-Rahhal et al.
PITUITARY (2009)
Prolactin/Leptin interactions in the control of food intake in rats
Lindsay Naef et al.
ENDOCRINOLOGY (2007)
Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma
Niki Karavitaki et al.
CLINICAL ENDOCRINOLOGY (2006)
Hypoadiponectinemia in lean lactating women: Prolactin inhibits adiponectin secretion from human adipocytes
Mikiko Asai-Sato et al.
ENDOCRINE JOURNAL (2006)
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy
O Serri et al.
CLINICAL ENDOCRINOLOGY (2006)
Focus on prolactin as a metabolic hormone
N Ben-Jonathan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Medication-induced hyperprolactinemia
ME Molitch
MAYO CLINIC PROCEEDINGS (2005)
Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue
L Nilsson et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Prolactin release is enhanced in proportion to excess visceral fat in obese women
P Kok et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Region-specific reduction in leptin-induced phosphorylation of signal transducer and activator of transcription-3 (STAT3) in the rat hypothalamus is associated with leptin resistance during pregnancy
SR Ladyman et al.
ENDOCRINOLOGY (2004)
Endothelial function, insulin sensitivity and inflammatory markers in hyperprolactinemic pre-menopausal women
D Yavuz et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2003)
Dopaminergic tone and obesity: an insight from prolactinomas treated with bromocriptine
M Doknic et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2002)
Prolactin: structure, function, and regulation of secretion
ME Freeman et al.
PHYSIOLOGICAL REVIEWS (2000)
Physiopathology of prolactin secretion in obesity
PG Kopelman
INTERNATIONAL JOURNAL OF OBESITY (2000)
分享论文
